Full name
BIOTARGET SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
20.14.Z - Manufacture of other organic basic chemicals
20.42.Z - Manufacture of perfumes and toilet preparations
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 95,2 | 117,9 | -418,2 | -454,7 |
EBITDA | 100,8 | 135,2 | -400 | -395,9 |
Short time liabilities | 577,1 | 78,3 | 550,2 | 602,9 |
Equity capital | 100,2 | 218 | -200,1 | -191,8 |
Operating profit (EBIT) | 100,8 | 135,2 | -400 | -395,9 |
Assets | 677,2 | 312,8 | 350,1 | 11,9 |
Net profit (loss) | 95,2 | 117,9 | -418,2 | -454,7 |
Cash | 60,7 | 270,2 | 29,4 | -89,1 |
Net income from sale | 361,5 | 352,5 | 127,5 | -63,8 |
Liabilities and provisions for liabilities | 577,1 | 94,8 | 550,2 | 480,7 |
Working assets | 669,9 | 305,5 | 342,8 | 12,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 95 | 54,1 | 209 | 154,9 |
Equity capital to total assets | 14,8 | 69,7 | -57,2 | -126,9 |
Gross profit margin | 26,3 | 33,4 | -328,1 | -361,5 |
EBITDA Margin | 27,9 | 38,3 | -313,8 | -352,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 583 | 81 | 1576 | 1495 |
Current financial liquidity indicator | 1.1608669757843018 | 3.223905563354492 | 0.6230165362358093 | -2,6 |
Net dept to EBITDA | 4.404325485229492 | -1.9986529350280762 | -1.221982717514038 | 0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane